All products are supplied for laboratory research use only — not for human or veterinary use.

Peptide Medix · Research catalog
SR9009 (Stenabolic) — research vial
  • HPLC tested for purity and identity; lot-matched COA available
  • Lot-matched certificate of analysis
  • Ships next business day, tracked

Metabolic & Circadian Compounds

SR9009 (Stenabolic)

Synthetic Rev-Erb nuclear receptor agonist studied in circadian and metabolic models

In stock·2 formats available·CAS 1379686-30-2
$55Range $55 – $68
Choose a format
Ask about this listing or request its COA
  • Mol. weight437.94 g/mol
  • Research areasCircadian gene expression, mitochondrial biogenesis, lipid and glucose handling, macrophage inflammatory signalling

Supplied for laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.

Overview

SR9009, widely known by the research label Stenabolic, is not a peptide. It is a synthetic small molecule developed as an agonist of the Rev-Erb nuclear receptors, REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These heme-binding receptors act as transcriptional repressors within the core circadian clock, linking the timing machinery of the cell to genes governing lipid and glucose metabolism, mitochondrial biogenesis and inflammatory signalling.

Its research profile stems from a set of rodent studies in which Rev-Erb agonism altered metabolic parameters and mitochondrial gene expression, producing the popular but imprecise description of an exercise mimetic. The published pharmacology carries important caveats: SR9009 shows poor oral bioavailability in reported mouse pharmacokinetics, and later work has argued that some of its cellular effects occur independently of Rev-Erb receptors, meaning target attribution cannot be assumed from phenotype alone.

SR9009 is not an approved drug in any jurisdiction, is not a dietary supplement, and is prohibited in sport by the World Anti-Doping Agency under the hormone and metabolic modulator category. MyPeptide supplies it as 10 mg capsules in bottles of 60 and as a 30 mL liquid at 20 mg/mL, HPLC tested with a lot-matched certificate of analysis. Sold for laboratory research use only.

Specifications

Identity

CAS number
1379686-30-2
Molecular formula
C20H24ClN3O4S
Molecular weight
437.94 g/mol

Supply & purity

Purity
HPLC tested for purity and identity; lot-matched COA available

Additional detail

Compound class
Synthetic small molecule; nuclear receptor (Rev-Erb) agonist — not a peptide
Molecular targets
REV-ERBα (NR1D1) and REV-ERBβ (NR1D2)
Also known as
Stenabolic, SR-9009
Available formats
10 mg × 60 capsules; 30 mL solution at 20 mg/mL
Mechanistic role
Enhances Rev-Erb transcriptional repression within the core circadian feedback loop
Research areas
Circadian gene expression, mitochondrial biogenesis, lipid and glucose handling, macrophage inflammatory signalling
Reported pharmacokinetics
Low oral bioavailability and short half-life reported in mouse studies
Regulatory status
Not approved as a medicine; not a dietary supplement; WADA-prohibited in sport
Storage
Cool, dry, dark; solution refrigerated and tightly capped

Questions about SR9009 (Stenabolic)

Is SR9009 a peptide or a SARM?

Neither. SR9009 is a synthetic small molecule that acts on the Rev-Erb nuclear receptors, which are circadian clock components. SARMs target the androgen receptor, and peptides are amino acid chains. SR9009 belongs to the metabolic modulator category rather than either of those.

What is the concern about off-target activity?

Published work found that SR9009 retained cellular activity in cells lacking both Rev-Erb receptors, which means at least some of its effects are not mediated by its nominal target. Experiments should include genetic controls rather than assuming that any observed change reflects Rev-Erb engagement.

What is its legal and regulatory status?

SR9009 is not approved as a medicine anywhere, is not a lawful dietary supplement ingredient, and is on the World Anti-Doping Agency prohibited list under hormone and metabolic modulators. It is offered here only as a research chemical for laboratory use.

Which format should a laboratory choose?

The 20 mg/mL liquid is easier to dilute accurately for in-vitro work, since volumes can be measured directly. The 10 mg capsules suit study designs that require a fixed unit format. The compound itself is identical between the two.

Related

Others in Metabolic & Circadian Compounds

View category

Metabolic & Circadian Compounds

SR9011

In stock2 sizes

from$55

SARMs

ACP-105

In stock2 sizes

from$55